Awards

Dr Banypersad has been honoured with a variety of prizes and grants

Prizes/Distinctions

1.

MRC grant (£2000) – Intercalated BMedSci, July 1998

2.

BJH Grant (£1000) – ISTH Conference, Washington DC, USA, Aug 1999

3.

Class 1 Hons Distinction – BMedSci, University of Sheffield, July 1999

4.

Enid-Linder Prize (£500) – undergraduate elective placement, University of Sheffield, March 2001

5.

Young Investigator Award (€1000) – International Amyloidosis Symposium, Holland, May 2012

6.

Young Investigator Award ($500) – AHA Early Career Award, Dallas, USA, Nov 2013

7.

Young Investigator Award – Early Career Award Finalist, SCMR, New Orleans, USA, Jan 2014

8.

Clinical Excellence Award – ELHT NHS Trust, Royal Blackburn Hospital, May 2018

9.

Clinical Excellence Award – ELHT NHS Trust, Royal Blackburn Hospital, May 2019

Invitations/Presentations

1.

Cardiac MRI simulator teaching – British Cardiovascular Society, Manchester Central, Manchester (June 2022)

2.

Top 10 Trials: MR INFORM study – British Cardiovascular Society, Manchester Central, Manchester (June 2019)

3.

Infiltrative Cardiomyopathies: Chaired session – British Society of Cardiovascular Imaging, EICC, Edinburgh (May 2018)

4.

Cardiac MRI in Infiltrative & Restrictive Heart Disease – British Society of CMR, Museum of Science & Industry, Manchester (Mar 2017)

5.

Cardiac MRI in Amyloid Heart Disease – North West CMR Study Day, Wythenshawe Hospital, Manchester (Nov 2015)

6.

Cardiac Amyloid Burden Assessment by T1 Mapping Predicts Survival in Systemic AL Amyloidosis: – SCMR, New Orleans, USA (Jan 2014­)

7.

T1 Mapping and Survival in AL Amyloidosis – AHA Scientific Sessions, Dallas, USA (Nov 2013)

8.

Changing Patients Outcomes with CMR – London CMR, The Heart Hospital, London (July 2013)

9.

ECV and T1 mapping – Cardiology Imaging Day, Royal Society of Medicine, London (Jun 2013)

10.

Organ Dysfunction in Systemic AL Amyloidosis using Equilibrium MRI to calculate ECV – EuroCMR, Florence, Italy (May 2013)

11.

Multi-Organ ECV as Measured by Eq-MRI in Systemic Amyloidosis – SCMR, San Francisco, USA (Feb 2013)

12.

Cardiac Disease in Systemic Amyloidosis as Measured by Eq-CMR – International Amyloidosis Symposium, Groningen, Holland (May 2012)

13.

Pre-Contrast ShMOLLI T1 mapping in Cardiac AL Amyloidosis – SCMR, Orlando, USA (Feb 2012)

14.

Assessing Cardiac Amyloidosis with CMR – London CMR, The Heart Hospital, London (Jan 2011)

We’re here to help

If you are uncertain on which service you might require for your needs, get in touch with Dr. Banypersad today.

Pulse Background Element